Ling Geoffrey M.D. 4
4 · Celularity Inc · Filed Oct 16, 2023
Insider Transaction Report
Form 4
Celularity IncCELU
Ling Geoffrey M.D.
Director
Transactions
- Award
Stock Option Grant (Right to Buy)
2023-08-31+1,250,000→ 1,250,000 totalExercise: $0.32Exp: 2033-08-31→ Class A Common Stock (1,250,000 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the Issuer's 2021 Equity Incentive Plan. The shares underlying such option will vest in three successive equal annual installments measured from the grant date, subject to the Reporting Person's continuous service with the Issuer through each such date.